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We examined the association of R577X polymorphism 
(rs!815739) in the a-actinin-3 (ACTN3) gene with "explo-
sive" leg muscle power performance in a group of male and 
female elite volleyball players (n = 66, 31 men, 35 women) 
and in a group of non-athletic male and female young adults 
(n = 334, 243 men, 91 women). We assessed power perfor-
mance by means of the vertical squat and counter-movement 
jump tests. We also determined whether the genotypic 
frequencies of the ACTN3 R577X genotypes differed be-
tween groups. We did not observe any effect of the ACTSV3 
The expression of the skeletal muscle protein 
a-aclinin-3 is almost exclusively restricted to fast 
twitch (type II) muscle fibers (Mills et al„ 2001), 
where it constitutes one of the major components of 
the Z-disc, This protein also stabilizes their muscle 
contractile apparatus, which may confer a higher 
capacity for force absorption/transmission compared 
with slow (type I) subtype (Mills et al.,-2001). More-
over, it was speculated that ot-actinin-3 promotes the 
formation of type II fibers through an interaction 
with the signaling protein calcincurin (Yang ct al., 
2003). 
In the late 1990s, North ct al. (1999) identified a 
C-to-T transition at nucleotide 1747 in exon 16 of the 
human a-actinin-3 {ACTN3) gene, which results in a 
stop codon (X) replacing the arginine (R) at amino 
acid 577 (R577X). The R577X variant results in two 
versions of the ACTN3 gene in humans, a functional 
R allele and a null X allele. More than a billion 
people worldwide are homozygous for the R577X 
null allele (i.e. they have the XX genotype), and thus 
cannot express a-aclinin-3 in their skeletal muscle 
fibers (MacArthur & North, 2004). 
Studies in animal models (MacArthur et al., 2007, 
2008) reported that the ACTN3 knockout mouse (a-
actinin-3 deficient) shows a decreased activity in the 
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R577X polymorphism on study phenotypes in both groups, 
regardless of gender (all P>0.05). Genotype frequencies 
were similar between volleyball and control groups 
(P = 0.095). Moreover, we did not And an association 
between the ACTN3 R577X polymorphism and the like-
lihood of being an elite volleyball player using the dominant 
(RR vs RX+XX) and the recessive model (RR+RX vsXX). 
In summary, these findings suggest that the ACTN3 R577X 
polymorphism does not influence explosive leg muscle power 
in elite volleyball players. 
anaerobic glycolytic pathway and an increased activ-
ity in the aerobic oxidative pathway. Further, knock-
out mice also exhibit better fatigue resistance, 
decreased muscle mass and fiber diameter of fast 
(I1B) twitch muscle fibers, and reduced muscular 
strength (MacArthur et al., 2007, 2008). As for 
humans, Yang et al. (2003) showed that, at least in 
women, it is almost impossible to find an Olympic 
finalist (not to mention an Olympic champion) in 
"power" or "sprint" events such as jumping, throw-
ing and 100 m running, with the ACTN3 XX geno-
type. These findings were replicated in other studies 
with elite sprint/power athletes (Nicmi & Majamaa, 
2005; Papadimitriou et al., 2008; Roth et al., 2008; 
Santiago et al., 2008; Eynon et al., 2009; Massidda et 
al., 2009). In contrast, we recently reported the case 
of an elite male long jumper bearing the XX geno-
type who participated in two Olympic games, with a 
personal best performance of 8 m 26 cm, including an 
8m jump at the age of 17 (i.e. a better performance 
than Carl Lewis at the same age) (Lucia et al., 2007). 
Another example of a power-oriented athlete with 
the XX genotype is a Russian world record holder in 
hammer throwing (Druzhevskaya et al., 2008). 
The effect of the ACTN3 genotype has mainly been 
studied in elite athletes, due to the fact that the 
influence on muscle function will be most readily 
observable at the extremes of human performance. In 
this regard, besides technical and tactical skills, 
muscular strength and "explosive" leg power are 
the most important factors contributing to successful 
performance during elite volleyball competitions 
(Marques & Gonzalez-Badillo, 2006). a-actinin-3 is 
a determinant factor for producing high-power, high-
velocity muscle contractions (MacArthur & North, 
2004). As such, the ACTN3 R577X polymorphism is 
a candidate gene to explain, at least partly, individual 
variations in volleyball performance. 
In order to examine the effect of the ACTN3 
R577X polymorphism on the ability to produce 
peak ("explosive") power across the human perfor-
mance continuum, we studied the association of the 
ACTN3 R577X polymorphism with leg muscle ex-
plosive power performance in a group of male and 
female elite volleyball players and in a group of non-
athletic male and female young adults. We also 
determined whether the genotypic frequencies of 
the ACTN3 R577X genotypes differ between groups. 
We hypothesized that (i) the ACTN3 R577X poly-
morphism is associated with jump performance in 
elite volleyball players, with the RR and RX geno-
type group having a better score than their XX 
counterparts and (ii) the XX genotype is under-
represented in the group of elite volleyball players. 
Methods 
Subjects 
The present study comprised 334 (243 men, 91 women) 
healthy young adults (University students) and 66 (31 men, 
35 women) elite volleyball players. All players belonged to the 
Spanish national team and competed at the international level, 
except 10 female players that were competing in the highest 
category at the national level. All participants were of the 
same Spanish (Caucasian) ancestry for at least three genera-
tions, and were free of any diagnosed cardiorespiratory dis-
ease. Participants from the control groups were physically 
active (Physical Education students), but were not engaged in 
competitive sports and performed less than one (power) or 
three (endurance) structured weekly training sessions within 
the last year. 
Written consent was obtained from each subject. The study 
protocol was approved by the institutional ethics committee 
[Universidad Europea de Madrid (UEM), Spain] and was in 
accordance with the Declaration of Helsinki for Human 
Research. 
Genotype assessment 
We extracted genomic DNA from saliva samples of university 
students (control group) and elite volleyball players during 
2008. Our study followed the recommendations for the human 
genotype-phenotype association (Chanock et al., 2007). 
Genotyping was originally performed during 2009 in the 
genetics laboratory of Universidad Europea de Madrid (Spain) 
following the methodology reported elsewhere (Lucia et al., 
2006). In brief, the polymerase chain reaction (PCR) was 
performed in order to amplify the sequence containing the 
mutation. A fragment of 303 bp was amplified using the 
following primers: forward CTGTTGCCTGTGGTAAGTG 
GG, with 5' VIC labeling, and reverse TGGTCACAGTATG 
CAGGAGGG. The PCR conditions were as follows: initial 
denaturing at 95 °C for 5min; 35 cycles at 95 °C for 30 s, at 
60 °C for 30 s, at 72 °C for 30 s and a final extension at 72 °C 
for lOmin. 
ACTN3 genotypes (rsl815739) were established by enzy-
matic digestion of amplicons with Dde I (Lucia et al., 2006). 
The R577X change creates a restriction site resulting in 
fragments of 108, 97 and 86 bp. Digestion of R577 allele 
results in fragments of 205 and 86 bp. Digestion products 
(108 bp for 577X and 205 bp for R577) were detected by 
capillary electrophoresis in an ABI Prism 310 genetic analyzer 
(Applied Biosystems, Foster City, California, USA). 
Phenotype assessment 
We assessed the squat (SJ) and counter-movement jump 
(CMJ) tests using an infrared contact timing platform (Globus 
Ergo Tester, Codogné, Italy) to evaluate leg muscles' ability to 
produce "explosive" power (Young et al., 2001). Details of the 
methodology used to assess jump performance can be found 
elsewhere (Santiago et al., 2009a). In brief, the SJ tests were 
performed without rebound or previous counter movement. 
Subjects kept both hands on the hips and trunk straight before 
and during jumps. Before the jumps, they reached 90° of knee 
flexion angle for ~ 1 s and during jumps, they could not 
perform hip or knee flexions (Bosco et al., 1982, 1983). For the 
CMJ tests, subjects started from a standing position, with 
trunk straight, legs extended and both hands on hips and 
performed a vertical jump with a prior fast counter movement 
allowing 90° knee flexion (Bosco et al., 1982, 1983). During 
jumps, they kept both hands on hips, trunk straight and they 
could not perform hip or knee flexions. 
Both tests were performed three times (each separated by a 
2-min rest period) and the best score was retained. These tests 
have shown to be reliable (Santiago et al., 2009a). The 
participants were encouraged to do their best when perform-
ing the tests and were advised not to perform any strenuous 
physical activity within the previous 48 h. One-week before the 
tests, all the participants received comprehensive instructions 
on the tests, after which a familiarization session took place. 
All the tests were performed during 2008 under the supervision 
of the same researchers. 
Statistical analysis 
We performed the analyses with the Statistical Package for 
Social Sciences (SPSS, v. 16.0 for WINDOWS; SPSS Inc., 
Chicago, Illinois, USA), and the level of significance was set at 
a < 0.05. We compared mean differences in the studied 
phenotypes between groups (control vs volleyball) using one-
way analysis of variance. We analyzed the differences in the 
study phenotypes among ACTN3 R577X genotypes in both 
the control and the volleyball group by regression analysis and 
one-way analysis of covariance after adjusting for weight, 
height and age. 
We compared genotype frequencies between groups as wells 
as between men and women using the chi-square test. We used 
logistic regression to calculate the odds ratio (OR) for being an 
elite volleyball player using both dominant (RR vs RX+XX) 
and recessive (RR+RX vs XX) models. 
Results 
Characteristics of study participants by sex and 
group are shown in Table 1. Volleyball players 
Table 1. Characteristics of study participants by sex and group 
Control Volleyball P* all P* men P* 
women 
All Men Women All Men Women 
Age (years) 21.0(1.9) 21.1(2.0) 20.5(1.6) 20.4(5.4) 18.2(2.5) 22.3(6.5) 0.125 <0.001 0.017 
Weight (kg) 69.4(10.7) 73.7(8.6) 57.8(6.4) 75.3(11.6) 83.2(10.5) 68.3(7.2) <0.001 <0.001 <0.001 
Heigh (cm) 173(8) 176(6) 164(6) 185(9) 192(6) 180(6) <0.001 <0.001 <0.001 
SJ 
Flight time (s) 540.3(51.3) 559.0(39.8) 490.4(45.0) 527.3(107.1) 574.1(45.0) 485.8(127.9) 0.625 0.056 0.006 
Vertical displacement 36.1(6.7) 38.5(5.5) 29.7(5.4) 35.5(9.4) 40.6(6.3) 30.9(9.3) 0.511 0.046 0.392 
of CG (cm) 
CMJ 
Flight time (s) 551.6(51.5) 570.8(40.9) 500.3(40.5) 566.8(56.9) 602.3(52.8) 535.3(39.5) 0.032 <0.001 <0.001 
Vertical displacement 37.6(6.9) 40.1(5.8) 30.9(5.0) 39.8(8.1) 44.8(7.89) 35.3(5.4) 0.026 <0.001 0.017 
of CG (cm) 
Values are means (standard deviation). Bold numbers means statistically significant. 
*Pfor group differences. 
CG, center of gravity; CMJ, counter-movement jump. 
were taller and heavier than individuals in the control 
group. Moreover, they performed better in the jump 
tests, which persisted after controlling for height 
(data not shown). 
The association between the ACTN3 R577X poly-
morphism and study phenotypes in both control and 
the volleyball groups is presented in Table 2. We did 
not observe any effect of the ACTN3 R577X poly-
morphism on study phenotypes in either group. We 
repeated the analyses separately in men (Table 3) and 
women (Table 4) and the results did not change 
significantly. 
The genotype distribution respected the Hardy-
Weinberg equilibrium in the control group 
(P = 0.595), but not in the volleyball group 
(P = 0.011 for men and women together, P= 0.092 
for men and P = 0.059 for women). Table 5 shows 
the genotype distribution of the ACTN3 R577X 
polymorphism in the control and volleyball groups, 
the OR and the 95% confidence interval (CI) for 
being a volleyball player. We did not observe sex 
differences in the control (%2 = 2.910, P = 0.233) or 
volleyball group (x2 = 0.078, P= 0.962). Genotype 
frequencies were similar between volleyball and con-
trol groups. Moreover, we did not find an association 
between the ACTN3 R577X polymorphism and the 
likelihood of being an elite volleyball player using the 
dominant or the recessive model. The results re-
mained unaltered when the analyses were adjusted 
for sex, weight, height and age (data not shown) or 
when performed for men and women separately 
(Table 5). 
Discussion 
The present study indicates that the ACTN3 R577X 
polymorphism is not associated significantly with the 
ability to produce peak ("explosive") power in elite 
volleyball players or in non-athletic people. We also 
observed that genotype frequencies were similar 
between volleyball and control groups. Taken to-
gether, these findings indicate that the ACTN3 
R577X polymorphism does not influence perfor-
mance in explosive power-oriented sports such as 
volleyball. 
These results were theoretically unexpected, given 
the role of a-actinin-3 on skeletal muscle phenotypes 
(MacArthur & North, 2004). Recent findings from 
association and case control studies are contradic-
tory. Whereas several studies showed no effect of the 
ACTN3 R577X polymorphism on muscular strength 
and power phenotypes (Moran et al., 2007; Delmo-
nico et al., 2008; Walsh et al., 2008; McCauley et al., 
2009; Santiago et al., 2009a), others reported an 
advantageous effect of the RR (Clarkson et al., 
2005; Moran et al., 2007; Vincent et al., 2007) or 
the XX (Delmonico et al., 2007) genotype. More-
over, although a lower prevalence of the XX geno-
type was observed in sprint/power athletes (Yang et 
al., 2003; Niemi & Majamaa, 2005; Papadimitriou et 
al., 2008; Roth et al., 2008; Santiago et al., 2008; 
Eynon et al., 2009; Massidda et al., 2009), notable 
exceptions have been reported. For instance, we 
described the case of a Spanish elite long jumper 
(two times Olympian, personal best of 8.26 m), whose 
genotype for the ACTN3 gene is 577XX (a-actinin-3 
deficient) (Lucia et al., 2007). Druzhevskaya et al. 
(2008) reported that a Russian world record holder in 
hammer throwing had also the XX genotype. 
McCauley et al. (2009) reported no influence of the 
ACTN3 R577X polymorphism on the absolute or 
relative torque at high velocities, the twitch response, 
and the isometric strength of the knee extensors in 
Caucasian adult men. Similarly, Clarkson et al. 
(2005) reported no association between the ACTN3 
Table 2. Mean (standard error) estimates of study phenotypes by genotypes of the ACTN3 R577X (rs1815739) polymorphism in the control and the volleyball group 
SJ 
Flight time (s) 
Vertical displacement of CG (cm) 
CMJ 
Flight time (s) 
Vertical displacement of CG (cm) 
Control 
RR (n=104) 
542.4 (4.2) 
36.4 (0.6) 
553.7 (4.2) 
37.9 (0.6) 
RX(n=169) 
543.0 (3.1) 
36.5 (0.4) 
553.1 (3.1) 
37.8 (0.4) 
XX(n=61) 
532.8 (5.3) 
36.1 (0.7) 
549.1 (5.2) 
37.3 (0.7) 
Padd, 
0.223 
0.217 
0.523 
0.547 
Pdom. 
0.680 
0.700 
0.739 
0.758 
P recess. 
0.090 
0.086 
0.465 
0.487 
Volleyball 
RR (n=14) 
529.9 (26.9) 
34.6 (2.2) 
546.6 (12.4) 
36.9 (1.7) 
RX(i?=43) 
532.0 (15.4) 
35.9 (1.2) 
570.9 (7.1) 
40.4 (1.0) 
XX(n=9) 
500.0 (34.1) 
34.3 (2.8) 
578.5 (15.7) 
41.2 (2.2) 
Padd, 
0.198 
0.968 
0.078 
0.090 
Pdom. 
0.241 
0.705 
0.067 
0.068 
P recess. 
0.402 
0.697 
0.382 
0.441 
Analyses were adjusted for sex, weight, height and age. 
Add., additive; CG, centre of gravity; CMJ, counter-movement jump; dom., dominant (RR vs RX+XX); recess., recessive (RR+RX vs XX); RR, major allele; SJ, squat jump; XX, minor allele. 
Table 3. Mean (standard error) estimates of study phenotypes by genotypes of the ACTN3 R577X (rs1815739) polymorphism in men of the control and the volleyball group 
SJ 
Flight time (s) 
Vertical displacement of CG (cm) 
CMJ 
Flight time (s) 
Vertical displacement of CG (cm) 
Control 
RR (n=77) 
561.1 (4.7) 
38.8 (0.6) 
572.8 (4.9) 
40.4 (0.7) 
RX(n=117) 
562.5 (3.6) 
39.0 (0.5) 
573.1 (3.8) 
40.5 (0.5) 
XX(i? = 49) 
552.5 (5.7) 
39.6 (0.8) 
569.5 (5.9) 
40.0 (0.8) 
Padd. 
0.306 
0.324 
0.707 
0.731 
Pdom. 
0.793 
0.828 
0.909 
0.922 
P recess. 
0.139 
0.143 
0.602 
0.627 
Volleyball 
RR(n=14) 
576.3 (14.5) 
40.9 (2.0) 
597.3 (16.1) 
77.2 (2.3) 
RX (n = 43) 
576.7 (8.4) 
41.0(1.2) 
606.1 (9.3) 
45.3(1.3) 
XX (n = 9) 
557.2 (19.8) 
38.2 (2.7) 
592.5 (21.9) 
43.2 (3.2) 
Padd. 
0.509 
0.469 
0.972 
0.906 
Pdom. 
0.799 
0.750 
0.786 
0.843 
P recess. 
0.392 
0.342 
0.680 
0.635 
Analyses were adjusted for weight, height and age. 
CG, center of gravity; CMJ, counter-movement jump; dom., dominant (RR vs RX+XX); recess., recessive (RR+RX vs XX); RR, major allele; SJ, squat jump; XX, minor allele. 
R577X polymorphism and isometric elbow flexor 
strength in men, yet they showed that women bearing 
the XX genotype had lower isometric strength than 
those with heterozygotes (RX). In a recent study, we 
also showed that the ACTN3 R577X polymorphism 
was not associated with jumping (vertical SJ and 
CM J tests) and sprint ability (30 m dash) in non-
athletic men and women (Santiago et al., 2009a). 
Moreover, we did not observe significant differences 
on genotype frequencies between those with the best 
or the worst power performance (i.e. > 90th vs 
<90th of the sex-specific percentile, respectively). 
In contrast, Vincent et al. (2007) showed that 
healthy young men with the RR genotype had 
significantly higher relative dynamic quadriceps tor-
ques at 300°/s and a greater percentage of type IIX 
fibers than those with the XX genotype. Additional 
controversy stems from the fact that Delmonico et al. 
(2007) observed that the XX genotype was associated 
with higher knee extensor concentric peak power 
compared with RR and RX genotypes in adults 
aged ~65 years. 
Naturally occurring jumping is a multi-joint move-
ment that involves the coordinated participation of 
the majority of lower limb muscles (Ashley & Weiss, 
1994; Brown & Weir 2001). During actual high 
muscle power actions (e.g. in team sport games), 
angular velocities at the hip or knee joints in the 
aforementioned actions can approach 800-1000°/s 
(Bosco et al., 1983). In this regard, the angular 
velocity in jump tests as those used in the present 
study is much higher than that of the phenotype tests 
applied in studies mentioned previously (Vincent 
et al., 2007; McCauley et al., 2009). In theory, a 
higher velocity may more effectively discriminate 
muscle function differences between genotypes. 
Volleyball requires players to be fast and explosive 
(Marques et al., 2009). A high and quick vertical 
jump is a critical factor in performance, as is a 
powerful spike to shoot the ball with high velocity. 
In fact, a good vertical jump height often precedes an 
effective setup, block or spike. Given the key role of 
a-actinin-3 on muscular strength and power (Ma-
cArthur & North, 2004), theoretically, the ACTN3 
R577X polymorphism might help in explaining, at 
least partly, individual variations in volleyball per-
formance-related phenotypes. The possibility of be-
coming an elite athlete depends on numerous factors, 
among which possessing a favorable genetic endow-
ment cannot be discarded (Ruiz et al., 2009; Santiago 
et al., 2009b). However, muscle phenotypes (e.g. 
"explosive" power) are complex traits likely not 
reducible to a single polymorphism as the one 
studied here. It is likely that epigenetic factors, 
environment and the complex gene-gene and gene-
environment interactions are also important deter-
minants. Further, there might be other genetic var-
Table 5. Genotype distribution in control and volleyball groups 
Genotype 
All 
RR 
RX 
XX 
P(R) 
4(X) 
Men 
RR 
RX 
XX 
P(R) 
4(X) 
Women 
RR 
RX 
XX 
P(R) 
4(X) 
Control 
n 
104 
169 
61 
77 
117 
49 
27 
52 
12 
% 
31.1 
50.6 
18.3 
0.56 
0.44 
31.7 
48.1 
20.2 
0.56 
0.44 
29.7 
57.1 
13.2 
0.58 
0.42 
Volleyball 
n 
14 
43 
9 
7 
20 
4 
7 
23 
5 
% 
21.2 
65.2 
13.6 
0.54 
0.46 
22.6 
64.5 
12.9 
0.55 
0.45 
20.0 
65.7 
14.3 
0.53 
0.47 
X2 (P-value) 
4.717 (0.095) 
0.314 (0.314) 
2.966 (0.227) 
0.019 (0.890) 
1.211 (0.546) 
0.597 (0.440) 
OR (95% CI) dom. 
1.680 (0.891-3.166) 
1.590 (0.657-3.850) 
1.687 (0.658-4.331) 
OR (95% CI) recess. 
0.368 (0.707-1.505) 
0.587 (0.196-1.755) 
1.097 (0.356-3.379) 
CI, confidence interval; dom., dominant (RR vs RX+XX); OR, odds ratio; recess., recessive (RR+RX vs XX); RR, major allele, XX, minor allele. 
iants not yet explored that could help to explain 
inter-individual variability in muscle phenotypes. 
Finally, beyond the genotype:phenotype association, 
the effect of micro-RNAs (miRNAs) on human 
muscle phenotypes remains to be determined (van 
Rooij et al., 2008). 
The fact that in the power group genotype dis-
tributions did not meet the Hardy-Weinberg equili-
brium must be kept in mind; yet, we believe it does 
not necessarily represent a major methodological 
limitation of our study. It is difficult to determine 
whether deviations from the Hardy-Weinberg equi-
librium in this relatively small sample are due to 
genetic drift, migration (i.e. gene flow), mutation 
(e.g. change in the rate of mutation from the R to 
the X allele of ACTN3 R577X polymorphism), 
selection or non-random mating, it should be noted 
that participants in the "control group" were physi-
cal education students, which may represent a se-
lected population sample, yet their ACTN3 R577X 
genotype frequencies (Table 5, RR: 31.1%; RX: 
50.6%; XX: 18.3%) are very similar to those ob-
served previously by us in 123 healthy, sedentary 
(non-physical education students) Spanish men (RR: 
28.5%; RX; 53.6%; XX: 17.9%) (Lucia et al., 2006). 
In summary, we did not observe an association 
between the ACTN3 R577X polymorphism and 
"explosive" power performance in elite volleyball 
players or in non-athletic physically young adults 
of both genders. Moreover, the genotypic frequencies 
of the ACTN3 R577X genotypes were similar be-
tween groups, suggesting that any influence of this 
polymorphism is not of a sufficient magnitude to 
influence jump performance in power athletes or in 
non-athletic Spanish Caucasian young adults. 
Perspectives 
a-actinin-3 is a sarcomeric protein that is almost 
exclusively expressed in fast muscle fibers, and seems 
crucial for producing fast and powerful contractions. 
The R577X variant results in two versions of the 
ACTN3 gene in humans, a functional R allele and a 
null X allele. It was hypothesized that, at least among 
women, it is almost impossible to find an Olympic in 
"power" or "sprint" events, such as jumping, throw-
ing and 100 m running, with the a-actinin-3-deficient 
(i.e. XX) genotype. This finding was replicated in a 
number of other studies, yet there are controversies, 
and there exist cases such as an Olympic-class long 
jumper with the ACTN3 XX genotype. The present 
study showed that the ACTN3 R577X polymorph-
ism does not influence performance in explosive 
power-oriented sports such as volleyball. The possi-
bility of becoming an elite athlete depends on numer-
ous factors. It is worth nothing that muscle 
phenotypes (e.g. "explosive" power) are complex 
traits that are likely not reducible to a single poly-
morphism. 
Key words: volleyball, squat jump, counter-movement 
jump, a-actinin-3, genotype. 
References 
Ashley CD, Weiss LW. Vertical jump 
performance and selected physiological 
characteristics of women. J Strength 
CondRes 1994: 8: 5-11. 
Bosco C, Mognoni P, Luhtanen P. 
Relationship between isokinetic 
performance and ballistic movement. 
Eur J Appl Physiol Occup Physiol 
1983: 51: 357-364. 
Bosco C, Viitasalo JT, Komi PV, 
Luhtanen P. Combined effect of elastic 
energy and myoelectrical potentiation 
during stretch-shortening cycle exercise. 
Acta Physiol Scand 1982: 114: 557-565. 
Brown LE, Weir JP. ASEP procedures 
recommendation I: Accurate 
assessment of muscular strength 
JEPonline. 2001: 4: 1-21. 
Chanock SJ, Manolio T, Boehnke M, 
Boerwinkle E, Hunter DJ, Thomas G, 
Hirschhorn JN, Abecasis G, Altshuler 
D, Bailey-Wilson JE, Brooks LD, 
Cardón LR, Daly M, Donnelly P, 
Fraumeni JF Jr, Freimer NB, Gerhard 
DS, Gunter C, Guttmacher AE, Guyer 
MS, Harris EL, Hoh J, Hoover R, 
Kong CA, Merikangas KR, Morton 
CC, Palmer LJ, Phimister EG, Rice JP, 
Roberts J, Rotimi C, Tucker MA, 
Vogan KJ, Wacholder S, Wijsman EM, 
Winn DM, Collins FS. Replicating 
genotype-phenotype associations. 
Nature 2007: 447: 655-660. 
Clarkson PM, Devaney JM, Gordish-
Dressman H, Thompson PD, Hubal 
MJ, Urso M, Price TB, Angelopoulos 
TJ, Gordon PM, Moyna NM, 
Pescatello LS, Visich PS, Zoeller RF, 
Seip RL, Hoffman EP. ACTN3 
genotype is associated with increases in 
muscle strength in response to 
resistance training in women. J Appl 
Physiol 2005: 99: 154-163. 
Delmonico MJ, Kostek MC, Doldo NA, 
Hand BD, Walsh S, Conway JM, 
Carignan CR, Roth SM, Hurley BF. 
Alpha-actinin-3 (ACTN3) R577X 
polymorphism influences knee extensor 
peak power response to strength 
training in older men and women. J 
Gerontol A Biol Sci Med Sci 2007: 62: 
206-212. 
Delmonico MJ, Zmuda JM, Taylor BC, 
Cauley JA, Harris TB, Manini TM, 
Schwartz A, Li R, Roth SM, Hurley 
BF, Bauer DC, Ferrell RE, Newman 
AB. Association of the ACTN3 
genotype and physical functioning with 
age in older adults. J Gerontol A Biol 
Sci Med Sci 2008: 63: 1227-1234. 
Druzhevskaya AM, Ahmetov II, 
Stratenkova IV, Rogozkin VA 
Association of the ACTN3 R577X 
polymorphism with power athlete 
status in Russians. Eur J Appl Physiol 
2008: 103: 631-634. 
Eynon N, Duarte JA, Oliveira J, Sagiv M, 
Yamin C, Meckel Y, Sagiv M, 
Goldhammer E. ACTN3 R577X 
polymorphism and Israeli top-level 
athletes. Int J Sports Med 2009: 30: 
695-698. 
Lucia A, Gomez-Gallego F, Santiago C, 
Bandres F, Earnest C, Rabadán M, 
Alonso JM, Hoyos J, Cordova A, Villa 
G, Foster C. ACTN3 genotype in 
professional endurance cyclists. Int J 
Sports Med 2006: 27: 880-884. 
Lucia A, Olivan J, Gomez-Gallego F, 
Santiago C, Montil M, Foster C. Citius 
and longius (faster and longer) with no 
alpha-actinin-3 in skeletal muscles? Br 
J Sports Med 2007: 41: 616-617. 
MacArthur DG, North KN. A gene for 
speed? The evolution and function of 
alpha-actinin-3. Bioessays 2004: 26: 
786-795. 
MacArthur DG, Seto JT, Chan S, 
Quinlan KG, Raftery JM, Turner N, 
Nicholson MD, Kee AJ, Hardeman 
EC, Gunning PW, Cooney GJ, Head 
SI, Yang N, North KN. An Actn3 
knockout mouse provides mechanistic 
insights into the association between 
alpha-actinin-3 deficiency and human 
athletic performance. Hum Mol Genet 
2008: 17: 1076-1086. 
MacArthur DG, Seto JT, Raftery JM, 
Quinlan KG, Huttley GA, Hook JW, 
Lemckert FA, Kee AJ, Edwards MR, 
Berman Y, Hardeman EC, Gunning 
PW, Easteal S, Yang N, North KN. 
Loss of ACTN3 gene function alters 
mouse muscle metabolism and shows 
evidence of positive selection in humans. 
Nat Genet 2007: 39: 1261-1265. 
Marques MC, Gonzalez-Badillo JJ. In-
season resistance training and 
detraining in professional team 
handball players. J Strength Cond Res 
2006:20: 563-571. 
Marques MC, van den Tillaar R, Gabbett 
TJ, Reis VM, Gonzalez-Badillo JJ. 
Physical fitness qualities of professional 
volleyball players: determination of 
positional differences. J Strength Cond 
Res 2009: 23: 1106-1111. 
Massidda M, Vona G, Calo CM. 
Association between the ACTN3 
R577X polymorphism and artistic 
gymnastic performance in Italy. Genet 
Test Mol Biomarkers 2009: 13: 377-
380. 
McCauley T, Mastana SS, Hossack J, 
Macdonald M, Folland JP. Human 
angiotensin-converting enzyme I/D 
and alpha-actinin 3 R577X genotypes 
and muscle functional and contractile 
properties. Exp Physiol 2009: 94: 8 1 -
89. 
Mills M, Yang N, Weinberger R, Vander 
Woude DL, Beggs AH, Easteal S, 
North K. Differential expression of the 
actin-binding proteins, alpha-actinin-2 
and -3, in different species: implications 
for the evolution of functional 
redundancy. Hum Mol Genet 2001: 10: 
1335-1346. 
Moran CN, Yang N, Bailey ME, 
Tsiokanos A, Jamurtas A, MacArthur 
DG, North K, Pitsiladis YP, Wilson 
RH. Association analysis of the 
ACTN3 R577X polymorphism and 
complex quantitative body 
composition and performance 
phenotypes in adolescent Greeks. Eur J 
Hum Genet 2007: 15: 88-93. 
Niemi AK, Majamaa K. Mitochondrial 
DNA and ACTN3 genotypes in 
Finnish elite endurance and sprint 
athletes. Eur J Hum Genet 2005: 13: 
965-969. 
North KN, Yang N, 
Wattanasirichaigoon D, Mills M, 
Easteal S, Beggs AH. A common 
nonsense mutation results in alpha-
actinin-3 deficiency in the general popu-
lation. Nat Genet 1999: 21: 353-354. 
Papadimitriou ID, Papadopoulos C, 
Kouvatsi A, Triantaphyllidis C. The 
ACTN3 gene in elite Greek track and 
field athletes. Int J Sports Med 2008: 
29: 352-355. 
Roth SM, Walsh S, Liu D, Metier EJ, 
Ferrucci L, Hurley BF. The ACTN3 
R577X nonsense allele is under-
represented in elite-level strength 
athletes. Eur J Hum Genet 2008: 16: 
391-394. 
Ruiz JR, Gomez-Gallego F, Santiago C, 
Gonzalez-Freire M, Verde Z, Foster C, 
Lucia A. Is there an optimum 
endurance polygenic profile? J Physiol 
2009: 587:1527-1534. 
Santiago C, Gonzalez-Freire M, 
Serratosa L, Morate FJ, Meyer T, 
Gomez-Gallego F, Lucia A. ACTN3 
genotype in professional soccer players. 
Br J Sports Med 2008: 42: 71-73. 
Santiago C, Rodriguez-Romo G, Gomez-
Gallego F, Gonzalez-Freire M, Yvert 
T, Verde Z, Naclerio F, Altmae S, 
Esteve-Lanao J, Ruiz JR, Lucia A. Is 
there an association between ACTN3 
R577X polymorphism and muscle power 
phenotypes in young, non-athletic 
adults? Scand J Med Sci Sports 2009a: 
doi: 10.1111/J.1600-0838.2009.01017.X 
Santiago C, Ruiz JR, Muniesa CA, 
Gonzalez-Freire M, Gomez-Gallego F, 
Lucia A. Does the polygenic profile 
determine the potential for becoming a 
world-class athlete? Insights from the 
sport of rowing. Scand J Med Sci 
Sports 2009b: 20: el88-el94. 
van Rooij E, Liu N, Olson EN. 
MicroRNAs flex their muscles. Trends 
Genet 2008: 24: 159-166. 
Vincent B, De Bock K, Ramaekers M, 
Van den Eede E, Van Leemputte M, 
Hespel P, Thomis MA. ACTN3 
(R577X) genotype is associated with 
fiber type distribution. Physiol 
Genomics 2007: 32: 58-63. 
Walsh S, Liu D, Metier EJ, Ferrucci L, 
Roth SM. ACTN3 genotype is 
associated with muscle phenotypes in 
women across the adult age span. J 
Appl Physiol 2008: 105: 1486-1491. 
Yang N, MacArthur DG, Gulbin JP, 
Hahn AG, Beggs AH, Easteal S, North 
K. ACTN3 genotype is associated with 
human elite athletic performance. Am J 
Hum Genet 2003: 73: 627-631. 
Young WB, MacDonald C, Flowers MA. 
Validity of double- and single-leg 
vertical jumps as tests of leg extensor 
muscle function. J Strength Cond Res 
2001: 15: 6-11. 
